Chunfang Tao1, Juan Luo1, Jun Tang1, Danfeng Zhou1, Shujun Feng2, Zhu Qiu1, Thomas C Putti3, Tingxiu Xiang1, Qiao Tao1,4, Lili Li5, Guosheng Ren6. 1. Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. 2. Hunan Province Key Laboratory of Tumor Cellular and Molecular Pathology, Cancer Research Institute, Hengyang School of Medicine, University of South China, Hengyang, China. 3. Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. 4. Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong and CUHK Shenzhen Research Institute, Hong Kong, China. 5. Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong and CUHK Shenzhen Research Institute, Hong Kong, China. lili_li@cuhk.edu.hk. 6. Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. rgs726@163.com.
Correction to: Clin Epigenetics 2020 Nov 17;12(1):173 https://doi.org/10.1186/s13148-020-00959-6
Following the publication of this article, the authors noted that images of MB231 group in Fig. 5C were misplaced by mistake. The corrected Fig. 5C is now shown in this correction. The authors confirm that the conclusions of this paper are not affected, and sincerely apologize for this error and any inconvenience that may have caused [1].